Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether injections of Å6 are effective in treating
ovarian cancer patients who have completed first-line therapy and currently have no
detectable cancer but have experienced a doubling of CA 125 levels.